Vanguard Group Inc Scynexis Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Scynexis Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,661,562 shares of SCYX stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,661,562
Previous 1,686,967
1.51%
Holding current value
$1.68 Million
Previous $2.51 Million
24.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SCYX
# of Institutions
53Shares Held
12.7MCall Options Held
9KPut Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.92 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.26 Million0.42% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.24 Million0.16% of portfolio
-
Amh Equity LTD626KShares$632,3120.79% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$561,1100.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $33M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...